Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Mirada Medical will be showcasing  and launching  new oncology imaging  software  designed to significantly improve productivity and communication between clinical specialists at the RSNA 2010

Mirada Medical Limited, the fast growing international company focused on advanced oncology imaging, announced that it will be showcasing  and launching  new oncology imaging  software  designed to significantly improve productivity and communication between clinical specialists at the 2010 RSNA ( Radiological Society of North America ) trade show in Chicago, Illinois from November 28 - December 3, 2010.

At the conference, Mirada will launch its novel solution for presenting  image based patient case information at specialist meetings such as tumor boards, multi-disciplinary team (MDT) meetings and radiology rounds. Users of Mirada’s technology will be able to greatly reduce the  time spent preparing multiple patient cases for presentation to the meeting, and will also
benefit  during the meeting  from having instant access to the advanced  visualisation and quantification features normally only available to the diagnostic reader.

Mirada will also be demonstrating the  unique oncology fusion workflows  of its XD3 image analysis software,  including new CT , MR, PET / CT and MR/PET analysis  tools designed  to enhance speed and accuracy across the complete spectrum of imaging tasks, from diagnosis and staging through to treatment response assessment and follow-up.

The new tools coupled with Mirada’s industry leading deformable registration technology and built-in support for  standard  and user-defined response assessment  protocols such as RECIST, WHO and PERCIST give the user exceptional power to review, compare and quantify a patient’s complete set of current and previous imaging studies.

Mirada Medical ’s team will be available to show how the referring physician can now have access to rich web-based fusion viewing capabilities, allowing them to view PET/CT, MR-PET and even CT-MR-PET fused  images,  reports and findings that the reading radiologist or nuclear medicine clinician has sent.  

Mirada Medical ’s  technologies are developed by world renowned scientists and dedicated engineers and the Company is focused on providing users with oncology imaging solutions to enhance their workflow whilst optimising the most accurate and consistent reporting and quantitative knowledge share in the multi-modal diagnosis and treatment of cancer.

Hugh Bettesworth, CEO of Mirada Medical, said: “We look forward to launching the final piece of our  innovative  suite of oncology imaging applications which together will offer not only the most advanced workflows in quantified diagnostic analysis of multi-modal images, but also significantly improve productivity and communication of findings when delivering these findings to the referring physician or presenting at specialist meetings such as tumor board. Mirada remains committed to the delivery of high quality healthcare solutions to its global customer base through the use of leading technologies.”

Mirada Medical will showcase its latest and industry leading developments  at Booth 7520,Hall B, North Building of McCormick Place.

Source: Mirada Medical